skip to main content
Idioma:
Resultados 1 2 3 next page
Refinado por: assunto: Biological And Medical Sciences remover assunto: Tumors remover Pharmacology. Drug Treatments remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer
Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer

NIETO, Yago ; VREDENBURGH, James J ; JONES, Roy B ; SHPALL, Elizabeth J ; BEARMAN, Scott I ; MCSWEENEY, Peter A ; CHAO, Nelson ; RIZZIERI, David ; GASPARETTO, Christina ; MATTHES, Steve ; BARON, Anna E

Clinical cancer research, 2004-11, Vol.10 (21), p.7136-7143 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
2
Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia
Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia

Thomas, Deborah A. ; Faderl, Stefan ; O'Brien, Susan ; Bueso‐Ramos, Carlos ; Cortes, Jorge ; Garcia‐Manero, Guillermo ; Giles, Francis J. ; Verstovsek, Srdan ; Wierda, William G. ; Pierce, Sherry A. ; Shan, Jianqin ; Brandt, Mark ; Hagemeister, Fredrick B. ; Keating, Michael J. ; Cabanillas, Fernando ; Kantarjian, Hagop

Cancer, 2006-04, Vol.106 (7), p.1569-1580 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
3
Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits
Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits

Yang, C. H. ; Gonzalez-Angulo, A. M. ; Reuben, J. M. ; Booser, D. J. ; Pusztai, L. ; Krishnamurthy, S. ; Esseltine, D. ; Stec, J. ; Broglio, K. R. ; Islam, R. ; Hortobagyi, G. N. ; Cristofanilli, M.

Annals of oncology, 2006-05, Vol.17 (5), p.813-817 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
4
anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells

Galustian, Christine ; Meyer, Brendan ; Labarthe, Marie-Christine ; Dredge, Keith ; Klaschka, Deborah ; Henry, Jake ; Todryk, Stephen ; Chen, Roger ; Muller, George ; Stirling, David ; Schafer, Peter ; Bartlett, J. Blake ; Dalgleish, Angus G

Cancer Immunology, Immunotherapy, 2009-07, Vol.58 (7), p.1033-1045 [Periódico revisado por pares]

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

Texto completo disponível

Citações Citado por
5
Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer
Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer

Bernhard, Helga ; Neudorfer, Julia ; Gebhard, Kerstin ; Conrad, Heinke ; Hermann, Christine ; Nährig, Jörg ; Fend, Falko ; Weber, Wolfgang ; Busch, Dirk H. ; Peschel, Christian

Cancer Immunology, Immunotherapy, 2008-02, Vol.57 (2), p.271-280 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

Citações Citado por
6
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination
Material Type:
Artigo 		Adicionar ao Meu Espaço

Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination

Vergati, Matteo ; Cereda, Vittore ; Madan, Ravi A ; Gulley, James L ; Huen, Ngar-Yee ; Rogers, Connie J ; Hance, Kenneth W ; Arlen, Philip M ; Schlom, Jeffrey ; Tsang, Kwong Y

Cancer Immunology, Immunotherapy, 2011-02, Vol.60 (2), p.197-206 [Periódico revisado por pares]

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

Texto completo disponível

Citações Citado por
7
Homeostasis of peripheral FoxP3⁺ CD4⁺ regulatory T cells in patients with early and late stage breast cancer
Homeostasis of peripheral FoxP3⁺ CD4⁺ regulatory T cells in patients with early and late stage breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Homeostasis of peripheral FoxP3⁺ CD4⁺ regulatory T cells in patients with early and late stage breast cancer

Rech, Andrew J ; Mick, Rosemarie ; Kaplan, David E ; Chang, Kyong-Mi ; Domchek, Susan M ; Vonderheide, Robert H

Cancer Immunology, Immunotherapy, 2010-04, Vol.59 (4), p.599-607 [Periódico revisado por pares]

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

Texto completo disponível

Citações Citado por
8
Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?

HALE, G ; SLAVIN, S ; GOLDMAN, J. M ; MACKINNON, S ; GIRALT, S ; WALDMANN, H

Bone marrow transplantation (Basingstoke), 2002-12, Vol.30 (12), p.797-804 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Successful Engraftment After Reduced-Intensity Umbilical Cord Blood Transplantation for Adult Patients with Advanced Hematological Diseases
Successful Engraftment After Reduced-Intensity Umbilical Cord Blood Transplantation for Adult Patients with Advanced Hematological Diseases
Material Type:
Artigo 		Adicionar ao Meu Espaço

Successful Engraftment After Reduced-Intensity Umbilical Cord Blood Transplantation for Adult Patients with Advanced Hematological Diseases

MIYAKOSHI, Shigesaburo ; YUJI, Koichiro ; MORI, Shin-Ichiro ; MORINAGA, Shin-Ichi ; MUTO, Yoshitomo ; MASUO, Shigeru ; KANEMARU, Mineo ; HAYASHI, Tatsuyuki ; TAKAUE, Yoichi ; TANIGUCHI, Shuichi ; KAMI, Masahiro ; KUSUMI, Eiji ; KISHI, Yukiko ; KOBAYASHI, Kazuhiko ; MURASHIGE, Naoko ; HAMAKI, Tamae ; KIM, Sung-Won ; UEYAMA, Jun-Ichi

Clinical cancer research, 2004-06, Vol.10 (11), p.3586-3592 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
10
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4⁺ T cells in a subset of cultures
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4⁺ T cells in a subset of cultures
Material Type:
Artigo 		Adicionar ao Meu Espaço

Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4⁺ T cells in a subset of cultures

Ingram, Wendy ; Kordasti, Shahram ; Chan, Lucas ; Barber, Linda D ; Tye, Gee J ; Hardwick, Nicola ; Mufti, Ghulam J ; Farzaneh, Farzin

Cancer Immunology, Immunotherapy, 2009-10, Vol.58 (10), p.1679-1690 [Periódico revisado por pares]

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2004  (2)
  2. 2004Até2006  (4)
  3. 2007Até2008  (4)
  4. 2009Até2011  (10)
  5. Após 2011  (9)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.